9999999997-15-002588.txt : 20150309 9999999997-15-002588.hdr.sgml : 20150309 20150309130917 ACCESSION NUMBER: 9999999997-15-002588 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150309 DATE AS OF CHANGE: 20150309 20150309 20150309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics plc CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0114 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-201807 FILM NUMBER: 15684421 BUSINESS ADDRESS: STREET 1: 85B PARK DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RY BUSINESS PHONE: 44-123-544-3939 MAIL ADDRESS: STREET 1: 85B PARK DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RY FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0W(#`@;V)J#3P\+TQI;F5AF4@-C`O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(*)-@O`(E/G0Q,C`S[0+(,C.C$?\:I?P`"#`#740?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU.2`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``)>>094P,@` MDN5H0!9C@6(&AAL,W`R7!E+U!A9V4^/@UE;F1O8FH--3`@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I\NMFF9UD4OUZN#"0%VU,"2$HP2-99]FNV+Z\6Q2[O&&W^4]V5^VR\CW9 M;K-=SLD"!M)_G5],JNWJRX+L\[;.V^6&WU;U+MN2ZKY#9(7@-VVV+9;7Y7J; M,\'G;;[[QF04\\7+4TZ^"+DNGMJJYM_[2K2Q5U=0)]:-+L=._U@NJU51KOE] M45Z73>'WLZ)NVNDFJ^'(_3.PV]!%_CGK'90Q?/[\HT4XB_HY)UP>'&1>M9OF MP=J$_4O!T8BB"-##:,#-&;H]^$E`J<`!C>2`1BM\`'[1[H+>$I_'BD%`GT:" M6:5@R"Q]W3J6TH.,DI1\<8VV5.O.%_?.#_8&9CW,0X6$2:.@*)-(#XQ`0K"& MQ.X;ZGU,OT[ZM;/[&``:!38"U3>`[*EF2@GZ&OR:OCDFP.%N(.Q!EB'HF6//T"Q_XE_<;[]"OL>?3[)O/J(\R;B-/$JY.3Q'LNY]K_ MF7.U&.@3&05M,AD]Y5B?3;E^-B&'$YS=5,F]-Q6^`_%3T[!@04OBOEWO&AOQ3`%?9DS+@:^JEPG>`[ ME`<9%_U.,RY63X0KY2O"=8SPBG#3Y`R^#1#8&$N/_1@XW2F^U2;:YUOYFF]U M<$5CP4+=OV\H/F@V]\"#`"#M'QZ M#0IE;F1S=')E86T-96YD;V)J#34Q(#`@;V)J#3P\+T9I;'1EC`-_Q./15XLDI"-5AW.G-%?G8LKW%O*DX4\C[E2R("-!D=6*KM2>)YFHRD< M8]X>F?2%)PL!L\Z8OW<"/H3?6T?QT<4`WMB-XTH^ZL'KZ.+&^6/T#HX$(1[N MCT02X]OLR-FZ.)N.5+3/O#S"J;Z(PNKA<%+(+QPWX/WWUV\=5_,1#NB-IFD! MZPT'C(:_.]+C_9\=U^>]X4].OI?U?\69*\>-X:',=MI)#QK2BF$#S&$(?@V" M7T#P#?RHJO_5+8I]F-[CT2QIB-!I2@2RC<#`GJZD\"JG'5X> MMO`=B"2H:DL<7`^(LVN&]%WWP-0>'Y:L$ZN,9@VKPTLG,9_,QLK:WB_$/DU< MPT<9\!X-T`C%XCHE"MPO:8,?M?D/,*+BFO,."S1T+CG&1>-(8$%53SP@^.F. MV*=I1LP@,4PZKN()/K1YU`^78.ZP#6]4Y="Z7<1P^ M):BE3[5:9.`VFM\[:((0/"<`SPGY)A_CHFPQA;4!I_&"*D-C M6`Q59CQGD[QQ M&XIXH'RU2)OV@$P:%(CO@(TU4K)"Y'N&_5LZZW*-1#]@ MKEY1(6Z6^4LT7R3"Z$B2D&6\';*/5D+5$JMAGNPJ05=4-2NB(EL4EF,T3W-H MG*J%4+^Q,>V2!,TLSHK:P+UQ\'=`N31NOKLE]W4C_L51'F?:RUL+RU'30[LH MG]UNJ3ZSVQ5R-4_-H?"8-\,+2K0J2I8PE*C6$B8K+8LO`G4RX8=[BTV;!U/-M^6[MS$YKLBP,<\ MPYUD=D:OX!\-AAN9D/1-3T2A,7"]_?F;O*%,>2AB460O8H=9,AE&[#JU2V9$ M2\G>HCB5Q)G5I,FJ$(BZX71CY=HD4Y-TJ!Q3"4I[%6LW0ED=`9EV02 M\@!T9'21/.6L[VQ6!\<:0_,F-:;?7+&6\WJ.*1ME-#LX:!`&$H+'1<)H\;:D1J$FP*A M&ET#B5[FS25`7C\69DM)6QMQHG9E+?6^I\63G`32#/M7<\@V+S&UR\[!S/-( M48+T+!F6AS65B$F>;5A1Y9>FU+L^=5FF+U)4(>O))<%+8PUHQ3WWK,TLP54O MSHB012WZV:9P+L.V*1L&)Q1R6TN/MTK4&&VHYDRI-;K+`R/$(@33K_8:/>A9 MVPI/>5D$*T6G"T]\K/`<'XSA^B>;!H_S=@BZ6OGJH'N5=Z2"?_++'7G6/1M@ MFS+/@P7_$\T3FY+)(#Y6=D5S?J4-E:J5DZ1RH6P2\J_1JO\9K6Z#KLI[I_:> M';K^KJ'+EX3N?Q/T(>:R3Q:I`6XQ*]6M0!US`]^#WI`]C8)V/E3)AWYV/H(7 M=@5)<]&38U[IEXSY\+]!6S7['D#?`@1HSPTP^@X`!B\),/XF@.;2N:,&$NYL MA"1JPQ`^%SK*.[P7K@9;)HKX$D-@M88MDKEK4,6''3O-PE<->"7\+'*>- M_B(6,BID=6OW1-,`F6;H^;OY:7%SZ4)#AAM()MWETEIS;CI0*5'/DA?HD@TQ M$D%X(O$+$$O3K(%TLJ'5P[35.-P90Z]M'Y?E[7[.S",+150T7:_,.2II-9YM MJMQ()'OI9V]YLM>#-9=H[^O;M"='RKD346B6%]_!M5\;P*<&!]II"^B&\M#T`5UHGJ'M;\F184+)TK"YRVL;\T>@E(53 M25Q[PIQ:'S;GQ:CSCP`#`*>$:?,-"F5N9'-TY!@9$1FEP'Z>@8V!F0$,$I.+"QP# M`GQ`[+S\O%0&#/#M&@,CB+ZL"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\!XLSR MD@*@.&,"D"V2E`UF@]2)9(<$.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0TM)2 MP3$E/RE5(;BRN"0UMUC!,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[CQ!#@.32HC(HDY')F($!(,``2<8X+PT*96YD MY)/=3MPP$$9?9=[`\8Q_$@FM1&F1*M3MBJ57B(L4+%@5DBAD)7C[?LEL MM^U%9Q^@-_EDS^38.8X3592I%JI)@E!#DIA\13'6Y#WE)I-GJAF!GH@(5->( M2(U')&H"(E.3$7BGJI`-4C)QA4Q(CP2)@?9<$PLR-L0!V53$$8N@B1,R,LVK M,?:$5B]8D,&3$$G`DYQ(P`M81\`+@IV#%Q+V#EZL*A+P(IH$O(COD7F_C1!: M?<*B`EZ*D0)XJ4X4P,OXA@!>#C5!A,^YH0!>#1EG9^X*EBJZ=IMV+-UT,Y8" M8W]/K,O;=%7>R;OK_KE\:0?8G#MNWH?BMM.XOU_:KOM^6JUFY"T$HV$6O(1H M!(VHD32R1JVQ@&>]2RB%E<)*8:6P4E@IK!16"BM%E")*$:6(4D0IHA11BBA% ME")*"4H)2@E*"4H)"^7.;6@!N*W;EGMUL-Z_O-[.?\G2L4R==UT_M=.N[]QV M:#MW\=2.D[O['XC[NVL>Q?3D.QWZX:(=?PT_=`]XM;CT_+N'Y]^AS][SK MRO:IQ5D*32'8][H?XX;8579K(I9#68UFM5D5K-9K-N9M9=YVYFUIWK;&MC4^\8_9UMBVQK8UMJVQ;8UM M:VQ;8]N:V-;$MB8GKN8_K?T48``@'M[K#0IE;F1S=')E86T-96YD;V)J#3(@ M,"!O8FH-/#PO3&5N9W1H(#0R,CDO4W5B='EP92]834PO5'EP92]-971A9&%T M83X^G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E M.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M8S`P,2`V M,RXQ,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D871A1&%T M93XR,#$U+3`S+3`Y5#$R.C$U.C$T+3`T.C`P/"]X;7`Z365T861A=&%$871E M/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D9CI$ M97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1)1#YU M=6ED.C`V9&(Q96$V+3-D934M-#)F.2TY-C(T+34Q,F)E-3$P9C@X-#PO>&UP M34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL;G,Z9&,] M(FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(B\^"B`@("`@("`@ M("`@(#PO"UD969A=6QT(B\^"B`@("`@ M("`@("`@(#PO&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N M8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@("`@(#QP9&8Z M2V5Y=V]R9',O/@H@("`@("`\+W)D9CI$97-C&UL;G,Z M<&1F>#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@ M("`\<&1F>#I3;W5R8V5-;V1I9FEE9#Y$.C(P,34P,S`Y,38Q-#4U/"]P9&9X M.E-O=7)C94UO9&EF:65D/@H@("`@("`@("`\<&1F>#I#;VUP86YY/E-E8W5R M:71I97,@86YD($5X:&%N9V4@0V]M;6ES#I#;VUP86YY/@H@ M("`@("`@("`\<&1F>#I#;VUM96YT#I#;VUM M96YT7!E+T]B:E-T;3X^+W^F#"H'=DL/GF*8(*#I_/!A$^"L>3CB!=4R*22.I-(=8\SU"W> MXX.>Z58W=]A,$"/WGMQ?T5PW;5N`W!_)IC+VYM,W MJ6JYO`@P`"2&6*D-"F5N9'-T!B8&ILE`0O`2D&#L`Q&F0(G; M9X`L!@;&H4PPW0(2C`P``08`CY8%90T*96YD